Trial Outcomes & Findings for Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty (NCT NCT02933671)
NCT ID: NCT02933671
Last Updated: 2022-07-19
Results Overview
The NRS 11 ranges from 0 (no pain) to 10 (intense pain).
Recruitment status
TERMINATED
Study phase
PHASE4
Target enrollment
11 participants
Primary outcome timeframe
4 hours postoperatively
Results posted on
2022-07-19
Participant Flow
Participant milestones
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Overall Study
STARTED
|
5
|
5
|
|
Overall Study
COMPLETED
|
5
|
5
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty
Baseline characteristics by cohort
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
Total
n=10 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
63.8 years
STANDARD_DEVIATION 6.0 • n=5 Participants
|
51.6 years
STANDARD_DEVIATION 17.8 • n=7 Participants
|
57.7 years
STANDARD_DEVIATION 14.1 • n=5 Participants
|
|
Sex: Female, Male
Female
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
5 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
9 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
5 Participants
n=5 Participants
|
5 Participants
n=7 Participants
|
10 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 4 hours postoperativelyThe NRS 11 ranges from 0 (no pain) to 10 (intense pain).
Outcome measures
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Numeric Pain Score at 4 Hours Postoperatively, as Measured by Numerical Rating Scale (NRS) 11
|
2.4 score on a scale
Standard Deviation 1.14
|
5.4 score on a scale
Standard Deviation 1.95
|
SECONDARY outcome
Timeframe: 24 hoursReported in IV morphine equivalents.
Outcome measures
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Cumulative Opioid Consumption
|
33.8 IV morphine equivalents in mg
Standard Deviation 24.0
|
41.9 IV morphine equivalents in mg
Standard Deviation 29.3
|
SECONDARY outcome
Timeframe: 4 hours postoperativelyReported as pounds per square inch (PSI).
Outcome measures
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Motor Strength, as Measured by Dynamometry
|
28.7 PSI
Standard Deviation 14.8
|
19.7 PSI
Standard Deviation 22.8
|
SECONDARY outcome
Timeframe: 24 hoursThe NRS 11 ranges from 0 (no pain) to 10 (intense pain).
Outcome measures
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Numeric Pain Score at 24 Hours, as Measured by NRS 11
|
2.6 score on a scale
Standard Deviation 1.9
|
5.2 score on a scale
Standard Deviation 1.3
|
SECONDARY outcome
Timeframe: post-op day 0Outcome measures
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 Participants
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 Participants
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Ambulation, as Measured by Distanced Walked
|
99.6 feet
Standard Deviation 122.2
|
20.8 feet
Standard Deviation 44.3
|
Adverse Events
Suprainguinal Fascia Iliaca (SIFI) Block
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Sham Group
Serious events: 0 serious events
Other events: 1 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Suprainguinal Fascia Iliaca (SIFI) Block
n=5 participants at risk
A nerve block technique using a numbing medication called ropivacaine.
Suprainguinal fascia iliaca (SIFI) block: An ultrasound guided nerve block using a medication that numbs the nerve called ropivacaine.
Ropivacaine: Local anesthetic (numbing drug)
|
Sham Group
n=5 participants at risk
The same nerve block technique as above, however using an inactive solution of salt water.
Sham block: An ultrasound guided nerve block using a medication that does NOT numb the nerve called saline, or salt water.
Saline: Salt water placebo
|
|---|---|---|
|
Musculoskeletal and connective tissue disorders
Motor weakness in the quadriceps and adductor group muscles
|
0.00%
0/5 • 24 hours from time of block
|
20.0%
1/5 • 24 hours from time of block
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place